Business description
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.
Management board & Supervisory board
| CEO |
| Stephen S. Schwartz |
| Management board |
| Herman Cueto, Jason W. Joseph, John O'Brien, Michael Paulo, Olga Pirogova, Luc Provost, Robin Vacha, David Wang, Rob Woodward, Ginger Zhou |
| Supervisory board |
| Frank E. Casal, Edward P. Bousa, Robyn C. Davis, Didier Hirsch, Martin D. Madaus, Erica J. McLaughlin, Tina S. Nova, Michael Rosenblatt |
Company data
| Name: |
Azenta Inc |
| Address: |
200 Summit Drive 6th Floor,Burlington, Massachusetts 01803 |
| Phone: |
+1-978-262-2626 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.azenta.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Medical Supplies |
| End of financial year: |
09-30 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
Sara Silverman |
| IR phone: |
+1-877-373-6374 |
| IR Fax: |
- |
| IR e-mail: |
ir@azenta.com
|
